Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Clinical trial NCT01953601 · TERMINATED

Trial details

NCT number: NCT01953601
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Amnestic Mild Cognitive Impairment Alzheimer's Disease Prodromal Alzheimer's Disease

Start date: 2013-11-05
Primary completion: 2018-04-17
Enrollment: 1454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.